{"id":3135,"date":"2011-02-11T16:04:29","date_gmt":"2011-02-11T21:04:29","guid":{"rendered":"http:\/\/sciencebusiness.technewslit.com\/?p=3135"},"modified":"2011-02-12T10:49:19","modified_gmt":"2011-02-12T15:49:19","slug":"finance-friday-11-february-2011","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=3135","title":{"rendered":"Finance Friday: 11 February 2011"},"content":{"rendered":"<figure id=\"attachment_142\" aria-describedby=\"caption-attachment-142\" style=\"width: 200px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/07\/CircleBenjamins_Photos8_200.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-142\" title=\"CircleBenjamins_Photos8_200\" src=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/07\/CircleBenjamins_Photos8_200.jpg\" alt=\"$100 bills in a circle (Photos8.com)\" width=\"200\" height=\"199\" srcset=\"https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/07\/CircleBenjamins_Photos8_200.jpg 200w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/07\/CircleBenjamins_Photos8_200-150x149.jpg 150w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/a><figcaption id=\"caption-attachment-142\" class=\"wp-caption-text\">(Photos8.com)<\/figcaption><\/figure>\n<p>Here are recent financial transactions for science- and engineering-based companies reported by <a href=\"http:\/\/www.xconomy.com\/\">Xconomy<\/a>.<\/p>\n<p><strong>Biomedical\/Life Sciences<\/strong><\/p>\n<p>AcelRx Pharmaceuticals in Redwood City, California. Pain medications. $40 million IPO: 8 million shares @ $5.00.<\/p>\n<p>Optimer Pharmaceuticals in San Diego, California. Antibiotics. $67.5 million stock offering: 6 million shares @ $11.25.<\/p>\n<p>Fluidigm in South San Francisco, California. $75.6 million IPO: 5.6 million shares @ $13.50.<\/p>\n<p>Arsanis in Lebanon, New Hampshire. Biotechnology. $9.6 million, equity.<\/p>\n<p>Marina Biotech in Bothell, Washington. Cancer drugs. $5.1 million, equity.<\/p>\n<p>Dendreon in Seattle, Washington. Cancer drugs. $80 million, debt.<\/p>\n<p>Oncothyreon in Seattle, Washington. Cancer drugs. $12.5 million, debt.<\/p>\n<p>Seattle Genetics in Bothell, Washington. Cancer drugs. $23.25 million stock offering: 1.5 million shares @ $15.50.<\/p>\n<p>Ecochlor in Acton, Massachusetts. Industrial anti-pathogen systems. $1.7 million, equity.<\/p>\n<p><strong>Physical Sciences<\/strong><\/p>\n<p>Shocking Technologies in San Jose, California, Polymer dielectric materials. $5.2 million, equity.<\/p>\n<p><strong>Engineering and Electronics<\/strong><\/p>\n<p>Tela Innovations in Los Gatos, California. Semiconductor fabrication. $4.75 million, equity.<\/p>\n<p>Read more: <a href=\"http:\/\/sciencebusiness.technewslit.com\/?p=2977\">Finance Friday: 28 January 2011<\/a><\/p>\n<p style=\"text-align: center;\">*\u00a0\u00a0\u00a0\u00a0 *\u00a0\u00a0\u00a0\u00a0 *<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Here are recent financial transactions for science- and engineering-based companies reported by Xconomy. Biomedical\/Life Sciences AcelRx Pharmaceuticals in Redwood City, California. Pain medications. $40 million IPO: 8 million shares @ $5.00. Optimer Pharmaceuticals in San Diego, California. Antibiotics. $67.5 million stock offering: 6 million shares @ $11.25. Fluidigm in South San Francisco, California. $75.6 million [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[37,23,24,19],"class_list":["post-3135","post","type-post","status-publish","format-standard","hentry","category-finance","tag-debt","tag-equity","tag-investment","tag-venture-capital"],"_links":{"self":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/3135","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3135"}],"version-history":[{"count":4,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/3135\/revisions"}],"predecessor-version":[{"id":3139,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/3135\/revisions\/3139"}],"wp:attachment":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3135"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3135"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}